Patients were followed from 1 year after cohort entry until a diagnosis of incident adverse CVEs, switch to a comparator drug, any cause of death or the end of the study (30 September 2022), whichever occurred first
Glucagon-like peptide-1 (GLP-1) receptor agonists are established treatments for type 2 diabetes mellitus and obesity in the UK, typically administered via subcutaneous injection
It also reduces cholesterol and triglycerides
Pregnancy naturally suppresses appetite-regulating signals and shifts energy metabolism toward fetal support, potentially offsetting some GLP-1 rebound effects once conception occurs
The Bottom Line GLP-1 is a peptide, but peptides encompass a vast category of signaling molecules throughout the body
Secondly, you want foods that are easier to tolerate